Table 3 Bacterial isolates treated with tigecycline and eradication rate.
From: Tigecycline use in serious nosocomial infections: a drug use evaluation
Bacterial isolates | n(%) | Microbiological efficacy n(%) | Microbiological failure n(%) |
|---|---|---|---|
Enterococcus faecium | 31 (24) | 22/31 (71) | 9/31 (29) |
Escherichia coli | 26 (20) | 21/26 (81) | 5/26 (19) |
Methicillin-resistant Staphylococcus aureus | 20 (15) | 16/20 (80) | 4/20 (20) |
Acinetobacter baumannii | 16 (12) | 11/16 (69) | 5/16 (31) |
Klebsiella pneumoniae | 15 (12) | 13/15 (89) | 2/15 (11) |
Enterobacter cloacae | 10 (8) | 8/10 (80) | 2/10 (20) |
Enterococcus faecalis | 6 (5) | 6/6 (100) | 0/6 |
Others | 5 (4) | 3/5 (60) | 2/5 (40) |
Total | 129 | 100/129 (78) | 29/129(22) |